secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001104659-26-038859
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents receives Nasdaq extension to Sept 28, 2026 for minimum bid price compliance
--------------------------------------------------------------------------------

- Received 180-day extension until Sept 28, 2026 to regain $1.00 minimum bid price compliance.
- Previously failed to meet compliance by March 31, 2026; had been notified in October 2025.
- Company considering options including reverse stock split to regain compliance.
- No assurance of regaining compliance; delisting risk remains.
- No immediate effect on listing or SEC reporting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465926038859/0001104659-26-038859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465926038859/tm2611004d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-038859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer